1.305USD+1.95%Mkt Cap: 837.18M USDP/E: —Last update: 2026-05-26
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment …
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap837.18M USD
Enterprise Value617.98M USD
Revenue (TTM)196.12M USD
Gross Profit179.14M USD
Net Income (TTM)-83.50M USD
Revenue/Share0.2940 USD
Last Price1.305 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees258
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS3741631036
Valuation
P/E (Trailing)—
P/E (Forward)19.38
PEG—
EV/EBITDA-17.86
EV/Revenue3.15
P/S4.12
P/B3.53
EPS (TTM)-0.11
EPS (Forward)0.07
52W Range
1.04027% of range2.010
52W High2.010 USD
52W Low1.040 USD
Profitability
Gross Margin97.42%
Oper. Margin-0.46%
EBITDA Margin-17.65%
Profit Margin-45.41%
ROE-36.97%
ROA-14.64%
Growth
Revenue Growth30.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-111.04M USD
CapEx (TTM)49.00K USD
FCF Margin-46.98%
FCF Yield-11.01%
Net Debt-190.33M USD
Net Debt/EBITDA5.50
Balance Sheet
Debt/Equity0.54
Current Ratio6.78
Quick Ratio4.85
Book Value/Sh0.3570 USD
Cash/Share0.4870 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1058:1000
Split DateJul 22, 2014
Analyst Consensus
Rating2.2 (Buy)
Target (Mean)3.400 USD
Target Range1.000 USD – 5.000 USD
# Analysts5
Ownership
Shares Out.641.52M
Float535.71M
Insiders0.08%
Institutions78.57%
Short Interest
Short Ratio4.2d
Short % Float11.82%
Short % Out.11.81%
Shares Short75.70M
Short (prev mo.)76.67M
Technical
SMA 501.535 (-15.0%)
SMA 2001.408 (-7.3%)
Beta0.68
S&P 52W Chg28.31%
Avg Vol (30d)14.98M
Avg Vol (10d)16.93M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—